Advertisement

Topics

Regeneron receives FDA approval for diabetic retinopathy drug

06:00 EDT 14 May 2019 | SmartBrief

Regeneron Pharmaceuticals' Eylea, or aflibercept injection, was approved by the FDA as treatment for diabetic retinopathy at  -More

Original Article: Regeneron receives FDA approval for diabetic retinopathy drug

NEXT ARTICLE

More From BioPortfolio on "Regeneron receives FDA approval for diabetic retinopathy drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...